Latest news
Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis: - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:51 GMTGrey Matters Appoints Radiologist Dr. Jayson A. Lord, MD as Medical Director of its First Dedicated PET Neuroimaging Clinic in the U.S. - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:25 GMTQuantum BioPharma's Dual Strategy Targets Neurological Health with MS Drug and Alcohol Supplement - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:51 GMTQuantum BioPharma Advances Dual Strategy for Neurological Health, Targeting MS and Alcohol Misuse - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:50 GMTQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances MS Imaging Study with Encouraging Preliminary Results - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 17:38:00 GMTQuantum Blockchain Technologies says Method C AI Oracle produced "consistent advantage" in Bitcoin mining tests - Proactive financial newsProactive financial news · Mon, 03 Aug 2026 07:17:08 GMT